Literature DB >> 29276578

New chemical and radiochemical routes to [18F]Rho6G-DEG-F, a delocalized lipophilic cation for myocardial perfusion imaging with PET.

J A H Inkster1,2, S Zhang1,2, V Akurathi1,2, A Belanger3, S Dubey3, T Treves2,3, A B Packard1,2.   

Abstract

New chemical and radiochemical syntheses are described for the preparation of n class="Chemical">[18F]Rho6G-DEG-F, an 18F-labeled analogue of the fluoresecent dye rhodamine 6G, which has shown promise as myocardidal perfusion imaging agent. Tosylated precursors of [18F]Rho6G-DEG-F amenable to 18F-labeling were obtained either through a two-step synthesis from rhodamine 6G lactone (33% yield), or in one step from rhodamine 575 (64% yield), then purified by preparative C18 chromatography. Manual synthesis of [18F]Rho6G-DEG-F was achieved in a single radiochemical step from either the tosylate salt or the tosylate/formate double salt in DMSO under standard nucleophillic aliphatic 18F-fluorination conditions (K[18F]F/K2CO3/Kryptofix 2.2.2.). Incorporation of the [18F]F- was found to be satisfactory (≥34% by TLC), despite the protic character of the precursor molecules. [18F]Rho6G-DEG-F was manually synthesized in final decay-corrected radiochemical yields of 11-26% (tosylate salt) and 9-21% (tosylate/formate double salt). The protocol was transferred to an automated synthesis unit, where the product was obtained in 3-9% radiochemical yield (n=3) decay corrected to start-of-synthesis, >99% radiochemical purity, and a molar activity of 122-267 GBq/μmol (3.3-7.2 Ci/μmol).

Entities:  

Year:  2017        PMID: 29276578      PMCID: PMC5739059          DOI: 10.1039/C7MD00326A

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  19 in total

Review 1.  Measuring mitochondrial function in intact cardiac myocytes.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Mol Cell Cardiol       Date:  2011-09-22       Impact factor: 5.000

2.  Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest.

Authors:  Jamshid Maddahi; Johannes Czernin; Joel Lazewatsky; Sung-Cheng Huang; Magnus Dahlbom; Heinrich Schelbert; Richard Sparks; Alexander Ehlgen; Paul Crane; Qi Zhu; Marybeth Devine; Michael Phelps
Journal:  J Nucl Med       Date:  2011-08-17       Impact factor: 10.057

3.  Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium.

Authors:  Igal Madar; Hayden T Ravert; Yong Du; John Hilton; Lana Volokh; Robert F Dannals; James J Frost; Joshua M Hare
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

4.  Synthesis and Bio-Evaluation of New (18) F-Labeled Pyridaben Analogs with Improved Stability for Myocardial Perfusion Imaging in Mice.

Authors:  Tiantian Mou; Zuoquan Zhao; Pu Zhang; Wei Fang; Cheng Peng; Jie Lu; Qian Wang; Yunchuan Ma; Xianzhong Zhang
Journal:  Chem Biol Drug Des       Date:  2015-01-12       Impact factor: 2.817

5.  Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.

Authors:  Ibrahim AlJammaz; Basim Al-Otaibi; Hussein AlHindas; Subhani M Okarvi
Journal:  Nucl Med Biol       Date:  2015-06-19       Impact factor: 2.408

6.  (18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines.

Authors:  Mark D Bartholomä; Shaohui Zhang; Vamsidhar Akurathi; Christina A Pacak; Patricia Dunning; Frederic H Fahey; Douglas B Cowan; S Ted Treves; Alan B Packard
Journal:  Nucl Med Biol       Date:  2015-06-18       Impact factor: 2.408

7.  Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).

Authors:  Mark D Bartholomä; Vijay Gottumukkala; Shaohui Zhang; Amanda Baker; Patricia Dunning; Frederic H Fahey; S Ted Treves; Alan B Packard
Journal:  J Med Chem       Date:  2012-12-14       Impact factor: 7.446

8.  Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.

Authors:  Daniel S Berman; Jamshid Maddahi; B K Tamarappoo; Johannes Czernin; Raymond Taillefer; James E Udelson; C Michael Gibson; Marybeth Devine; Joel Lazewatsky; Gajanan Bhat; Dana Washburn
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

9.  Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: comparison with 99mTc-tetrofosmin.

Authors:  Igal Madar; Hayden Ravert; Antony Dipaula; Yong Du; Robert F Dannals; Lewis Becker
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

10.  Radiosynthesis of 11-[(18) F]fluoroundecyltriphenylphosphonium (MitoF) as a potential mitochondria-specific positron emission tomography radiotracer.

Authors:  L Li; L Brichard; L Larsen; D K Menon; R A J Smith; M P Murphy; F I Aigbirhio
Journal:  J Labelled Comp Radiopharm       Date:  2013-09-10       Impact factor: 1.921

View more
  1 in total

Review 1.  Fluorine-18-Labeled Fluorescent Dyes for Dual-Mode Molecular Imaging.

Authors:  Maxime Munch; Benjamin H Rotstein; Gilles Ulrich
Journal:  Molecules       Date:  2020-12-21       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.